Skip to content

LIMN — Liminatus Pharma Inc. Institutional Holders · Q2 2026

Who owns Liminatus Pharma Inc. (LIMN)? 18 institutions reported holding $105,097 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Cygnus Capital Advisors, LLC ($36,000), XTX Topco Ltd ($24,491), Geode Capital Management, LLC ($15,282).

RankInstitutionValueSharesChange
1Cygnus Capital Advisors, LLC$36,000329,333Trimmed
2XTX Topco Ltd$24,491221,839New
3GEODE CAPITAL MANAGEMENT, LLC$15,282138,418Added
4VANGUARD GROUP INC$8,07673,424Hold
5CITADEL ADVISORS LLC$6,19256,089Trimmed
6GOLDMAN SACHS GROUP INC$4,44040,220New
7StoneX Group Inc.$3,93426,058New
8STATE STREET CORP$2,09819,000Hold
9UBS Group AG$1,84016,730Trimmed
10Vanguard Personalized Indexing Management, LLC$1,45213,148Trimmed
11Tower Research Capital LLC (TRC)$7837,093Trimmed
12BARCLAYS PLC$4744,290New
13BlackRock, Inc.$35313Trimmed
14TWO SIGMA SECURITIES, LLC$00Exited
15Virtu Financial LLC$00Exited
16JANE STREET GROUP, LLC$00Exited
17Farther Finance Advisors, LLC$00Exited
18CITIGROUP INC$00Exited

Source: SEC Form 13F filings · as of 2026-06-30